Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Boards Stock Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 474
Posts 66,472
Boards Moderated 2
Alias Born 03/31/08
160x600 placeholder
S&P 500 Closes At Record On Strong Earnings
Gains in health care and technology sector stocks on the back of impressive profits from Biogen Idec Inc. and Apple Inc. pushed the S&P 500 to close at a record on Wednesday.
Top Equities Stories Of The Day
Crash Investigators Face Difficult Task in Ukraine
European Stocks Slip; Shire Leads FTSE Gains
Apple, Microsoft Fuel Broad Tech Gains
Taiwan Export Orders Point to Stronger Global Demand
Glaxo Slides In London After Earnings Warning
Correction to Facebook Earnings Story, Market Talk
U.S. Hot Stocks: Hot Stocks to Watch
Judge Delays Decision on Argentine Bonds
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81212 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist